Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00802425
Other study ID # AM-111-CL-08-01
Secondary ID EudraCT number 2
Status Completed
Phase Phase 2
First received December 3, 2008
Last updated June 24, 2014
Start date December 2008
Est. completion date October 2012

Study information

Verified date June 2014
Source Auris Medical, Inc.
Contact n/a
Is FDA regulated No
Health authority Germany: Federal Institute for Drugs and Medical DevicesPoland: The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products.Czech Republik: State Institute for Drug Control
Study type Interventional

Clinical Trial Summary

The purpose of the study is to determine whether AM-111 is effective in the treatment of acute inner ear hearing loss (acute sensorineural hearing loss, ASNHL).


Recruitment information / eligibility

Status Completed
Enrollment 210
Est. completion date October 2012
Est. primary completion date July 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Patients with unilateral acute sensorineural hearing loss (ASNHL) with onset 48 hours or less ago

- Mean earing loss compared with the unaffected contralateral ear of at least 30 dB in the 3 most affected contiguous frequencies

- Age = 18 years and = 60 years

- Negative pregnancy test for women of childbearing potential

- Able to attend the on-study visits

- Written informed consent before participation in the study

Exclusion Criteria:

- Bilateral ASNHL, if not resulting from acoustic trauma

- Suspected perilymph fistula or membrane rupture

- Barotrauma

- Average air bone gap higher than 20 dB in 3 contiguous frequencies

- History of Meniere disease, autoimmune hearing loss, radiation-induced hearing loss, endolymphatic hydrops, suspected retro-cochlear lesion or fluctuating hearing loss

- Previous ASNHL incident within the past 6 weeks

- Evidence of acute or chronic otitis media or otitis externa on examination

- Any drug-based therapy for inner ear hearing loss that is ongoing or was performed in the past 2 weeks

- Any ongoing or planned concomitant medication for the treatment of tinnitus until 30 days after administration

- Any therapy known as ototoxic (e.g. aminoglycosides, cisplatin, loop diuretics, quinine etc.) in the past 6 months prior to study inclusion

- History of drug abuse or alcoholism

- Any clinically relevant respiratory, cardiovascular, neurological (except vertigo or tinnitus), or psychiatric disorders

- Known hypersensitivity, allergy or intolerance to the study medication or any history of severe abnormal drug reaction

- Women who are breast-feeding, pregnant or who plan a pregnancy during the trial

- Women of childbearing potential who declare being unwilling or unable to practice contraception such as combined oral contraceptives, injectables, hormonal intra-uterine devices, vasectomised partner or sexual abstinence

- Concurrent participation in another clinical trial or participation in another clinical trial within 30 days prior to study entry

- Any current anticoagulant therapy (e.g. Aspirin, Marcumar, etc)

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
AM-111
single intratympanic injection
placebo
single intratympanic injection

Locations

Country Name City State
Germany LMU Munich Klinikum Grosshadern Munich

Sponsors (1)

Lead Sponsor Collaborator
Auris Medical AG

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hearing loss Average change in hearing loss in dB between the baseline and D7 for the three contiguous frequencies with the worst hearing loss, identified at study entry 7 days No
Secondary Hearing loss Average change in hearing loss in dB between the baseline and D3, D30, and D90 for the three contiguous frequencies with the worst hearing loss, identified at study entry Days 3, 30, 90 No
See also
  Status Clinical Trial Phase
Recruiting NCT04696835 - fNIRS in Pediatric Hearing Aids N/A
Completed NCT03662256 - Reducing Childhood Hearing Loss in Rural Alaska Through a Preschool Screening and Referral Process Using Mobile Health and Telemedicine N/A
Completed NCT04602780 - Evaluating the Revised WORQ in CI Users
Completed NCT03723161 - Evaluation of the Ponto Bone Anchored Hearing System in a Pediatric Atresia Population
Completed NCT05086809 - Investigation of an Updated Bone-anchored Sound Processor N/A
Active, not recruiting NCT03548779 - North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2 N/A
Completed NCT03428841 - Audiovisual Assessment After Dural Puncture During Epidural Placement in Obstetric Patients N/A
Completed NCT04559282 - Home Test of New Sound Processor N/A
Enrolling by invitation NCT03345654 - Individually-guided Hearing Aid Fitting
Completed NCT06016335 - MRI-based Synthetic CT Images of the Head and Neck N/A
Completed NCT05165121 - Comparison of Hearing Aid Fitting Outcomes Between Self-fit and Professional Fit for MDHearing Smart Hearing Aids N/A
Recruiting NCT05533840 - Establishment and Application of a New Imaging System for Otology Based on Ultra-high Resolution CT
Terminated NCT02294812 - Effects of Cognitive Training on Speech Perception N/A
Completed NCT04622059 - AUditive Direct In-utero Observation (AUDIO): Prenatal Testing of Congenital Hypoacusis N/A
Recruiting NCT02558478 - Identification of New Genes Implicated in Rare Neurosensory Diseases by Whole Exome Sequencing N/A
Withdrawn NCT02740322 - Validating the Hum Test N/A
Completed NCT01963104 - Community-Based Kiosks for Hearing Screening and Education N/A
Completed NCT01892007 - Evaluation of Cogmed Working Memory Training for Adult Hearing Aid Users N/A
Completed NCT01857661 - The Influence of the Sound Generator Combined With Conventional Amplification for Tinnitus Control: Blind Randomized Clinical Trial N/A
Withdrawn NCT01223638 - The Prevalence of Hearing Loss Among Children With Congenital Hypothyroidism N/A